MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)

NCT00996801 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

526

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis
Postmenopausal Osteoporosis

Interventions

DRUG: MK-5442
DRUG: Placebo to MK-5442
DRUG: Alendronate Sodium
DRUG: Vitamin D3
DRUG: Calcium carbonate
DRUG: Placebo to Alendronate

Sponsor

Merck Sharp & Dohme LLC